Delivery Order SPE2DB20D2104-SPE2DB22FT95P

Award Date 9/16/22
Potential Completion Date 9/19/22
Potential Value $3.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a prime contractor and subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,973.68 firm fixed price delivery order is for the supply of Prolia 60 mg/ml syringes, a specialty pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,605.33 firm fixed-price delivery order is for the supply of Prolia 60 mg/ml syringes, a specialty medication used for the treatment of various medical conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,714.50 firm fixed-price delivery order is for PROLIA 60 MG/ML SYRINGEML, a prescription medication, with a period of performance through January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $31,449.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of PROLIA 60 MG/ML syringes, a specialty medication used in various medical treatments. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Prolia 60 mg/ml syringes. The award, with a ceiling value of $2,230.89, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen. The IDC with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026,...
This federal contract award, valued at $13,685.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for Prolia 60 mg/ml syringes, a specialty medication used in the treatment of various medical conditions. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,032.70 firm fixed-price delivery order is for the supply of Prolia 60 mg/ml syringes, a specialty medication used for the treatment of various medical conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.44 delivery order is for the supply of the drug Prolia 60 mg/ml syringes. The contract has a firm fixed price and is set to be completed by May 2, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,850.78 delivery order contract is for the supply of Prolia 60 mg/ml syringes, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,990.06 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which serves as a primary vehicle for providing a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FT95P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,625.68 firm fixed-price delivery order covers the supply of Prolia 60 mg/mL syringes, a specialty medication used for the treatment of various medical conditions.

The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, enables the DLA to efficiently procure essential medications and medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract award did not include any set-aside designation, indicating open competition.

Generated 2/27/25, 11:58 AM